Results 171 to 180 of about 72,343 (275)

The Evolution of Initial Global Aphasia: Implications for Prognosis [PDF]

open access: green, 1985
Audrey L. Holland   +2 more
openalex  

Relationship between age and severity of cognitive impairment at diagnosis for early‐onset and late‐onset Alzheimer's disease: Comparison of LEADS and ADNI

open access: yesAlzheimer's &Dementia, Volume 22, Issue 2, February 2026.
INTRODUCTION Recent work has identified unique cognitive profiles for early‐onset Alzheimer's disease (EOAD) relative to late‐onset Alzheimer's disease (LOAD), however, examination has been limited in determining whether the association between age and cognitive severity at presentation also differs across conditions.
Dustin B. Hammers   +40 more
wiley   +1 more source

Urinary tract infection‐related delirium in Alzheimer's disease and related dementias: Clinical challenges and translational opportunities

open access: yesAlzheimer's &Dementia, Volume 22, Issue 2, February 2026.
Abstract Alzheimer's disease and related dementias (ADRD) affects millions of patients worldwide and is a leading cause of morbidity in older adults. Patients with ADRD are particularly susceptible to developing urinary tract infection (UTI) and UTI‐related delirium, creating a self‐perpetuating cycle in which ADRD increases vulnerability to infection ...
Sarah Kim   +3 more
wiley   +1 more source

Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia [PDF]

open access: bronze, 2016
Maria Luisa Mandelli   +15 more
openalex   +1 more source

Bispecific Antibodies Versus Chimeric Antigen Receptor T‐Cell Therapy in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma: A Comparative Narrative Review of Efficacy, Safety, and Accessibility

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Introduction Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin lymphoma, and despite advances in frontline therapies such as rituximab, cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone, approximately 30%–40% of patients develop relapsed or refractory (
Dana Sofian Abou   +6 more
wiley   +1 more source

Comment on Panuccio et al. Quality of Assessment Tools for Aphasia: A Systematic Review. <i>Brain Sci.</i> 2025, <i>15</i>, 271. [PDF]

open access: yesBrain Sci
Wallace SJ   +10 more
europepmc   +1 more source

Initially Normal MRI, Delayed Splenial Lesion in Marchiafava‐Bignami Disease

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Marchiafava–Bignami disease (MBD) may show normal findings on early MRI. In patients with alcohol use disorder or risk of thiamine deficiency, repeat imaging is important because splenial lesions can develop later. Recognizing this pattern is key to avoiding delayed diagnosis.
Tsuyoshi Nojima   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy